Shanghai Kehua Bio-Engineering Co.,Ltd (002022.SZ) SHZ
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In CNY
Sector
Healthcare
Industry
Medical - Devices
Employees
2151
First IPO Date
July 21, 2004
| Name | Title | Pay | Year Born |
| Xian Feng Zang | Financial Director | 0 | 1975 |
| Baogang Miao | Vice President & Non-Independent Director | 0 | 1976 |
| Jiaming Liang | Vice President & Non-Independent Director | 0 | 1982 |
| Ming Li | Chairman & President | 0 | 1976 |
| Hongying Jin | Vice President, Board Secretary & Non Independent Director | 0 | 1972 |
| Shin Kang Hyuk | Vice President | 0 | 1967 |
| Lei Yu | Accounting Supervisor | 0 | N/A |
Shanghai Kehua Bio-Engineering Co.,Ltd (SKBE), founded in 1981 and headquartered in Shanghai, China, is a leading enterprise specializing in the research, development, manufacturing, and sale of in vitro diagnostic (IVD) products. While primarily serving the Chinese market, the company also has a significant international presence, exporting its Kehua-branded products to 38 countries and regions worldwide. SKBE's extensive product portfolio encompasses a wide array of diagnostic kits and reagents. These include tests for various infectious diseases, such as different forms of hepatitis (HBV, hepatitis B, HCV), HIV, and syphilis (including rapid plasma regain and Treponema pallidum antibodies). They also offer kits for detecting cancer markers like alpha-fetoprotein and carcino-embryonic antigen (CEA), as well as general health indicators such as fecal occult blood. The company is actively innovating in the field of renal disease diagnostics, aiming to provide solutions for screening, diagnosis, and monitoring treatment effectiveness. Beyond reagents, SKBE manufactures a comprehensive range of laboratory equipment and automated analysis systems crucial for clinical laboratories and medical institutions. This includes automated biochemical analysis systems, nucleic acid blood screening systems, and automatic chemiluminescence measuring systems. They also provide essential lab tools such as microplate readers, plate washers, specialized reagent packaging systems, and electrolyte analyzers. Furthermore, SKBE acts as a distributor for various external diagnostic systems, encompassing automated chemiluminescence, microbial, blood, and urine analysis systems, along with their associated supplies and other biochemical analyzers. The company extends its services to establishing and supporting third-party medical laboratory centers. They offer comprehensive solutions that span planning and design, management consulting, equipment and reagent supply, supply chain optimization, and direct medical testing services. SKBE is also committed to various social medical initiatives.